| abstract |
The application provides a chimeric antibody immune cell conjugate comprising a target cell binding domain that specifically binds an antigen on a target cell and an immune effector cell binding domain that includes an antigen-binding fragment that specifically binds an antigen on an immune effector cell . Also provided are pharmaceutical compositions, kits and methods of treatment. |